57794-0

Newborn screening test results panel - DBS

Active

Panel Hierarchy

Details for each LOINC in Panel LHC-Forms

LOINC	Name	R/O/C	Cardinality	Example UCUM Units
57794-0	Newborn screening test results panel - Dried blood spot	C
Indent53261-4	Amino acid newborn screen panel	C
IndentIndent46733-2	Amino acidemias newborn screen interpretation	C
IndentIndent57710-6	Amino acidemias newborn screening comment-discussion	C
IndentIndent57793-2	Amino acidemia disorder suspected [Identifier] in DBS	C
IndentIndent46746-4	Phenylketonuria and variants/Biopterin defects newborn screen interpretation	C
IndentIndent58231-2	Phenylketonuria and variants/Biopterin defects newborn screening comment-discussion	C
IndentIndent46743-1	Maple syrup urine disease newborn screen interpretation	C
IndentIndent58230-4	Maple syrup urine disease newborn screening comment-discussion	C
IndentIndent47539-2	3-Methylhistidine [Moles/volume] in DBS	C		umol/L
IndentIndent53232-5	5-Oxoproline+Pipecolate [Moles/volume] in DBS	C		umol/L
IndentIndent53394-3	5-Oxoproline+Pipecolate/Phenylalanine [Molar ratio] in DBS	C		{Ratio}
IndentIndent53150-9	Alanine+Beta Alanine+Sarcosine [Moles/volume] in DBS	C		umol/L
IndentIndent53393-5	Alloisoleucine+Isoleucine+Leucine+Hydroxyproline+Valine/Phenylalanine+Tyrosine [Molar ratio] in DBS	C		{Ratio}
IndentIndent53152-5	Alloisoleucine+Isoleucine+Leucine+Hydroxyproline [Moles/volume] in DBS	C		umol/L
IndentIndent53153-3	Alloisoleucine+Isoleucine+Leucine+Hydroxyproline/Phenylalanine [Molar ratio] in DBS	C		{Ratio}
IndentIndent53154-1	Alloisoleucine+Isoleucine+Leucine+Hydroxyproline/Alanine [Molar ratio] in DBS	C		{Ratio}
IndentIndent47562-4	Arginine [Moles/volume] in DBS	C		umol/L
IndentIndent75214-7	Arginine/Ornithine [Molar ratio] in DBS	C		{ratio}
IndentIndent53398-4	Arginine/Phenylalanine [Molar ratio] in DBS	C		{Ratio}
IndentIndent53062-6	Argininosuccinate [Moles/volume] in DBS	C		umol/L
IndentIndent53200-2	Argininosuccinate/Arginine [Molar ratio] in DBS	C		{Ratio}
IndentIndent53155-8	Asparagine+Ornithine [Moles/volume] in DBS	C		umol/L
IndentIndent53395-0	Asparagine+Ornithine/Serine [Molar ratio] in DBS	C		{Ratio}
IndentIndent53396-8	Asparagine+Ornithine/Phenylalanine [Molar ratio] in DBS	C		{Ratio}
IndentIndent47573-1	Aspartate [Moles/volume] in DBS	C		umol/L
IndentIndent42892-0	Citrulline [Moles/volume] in DBS	C		umol/L
IndentIndent54092-2	Citrulline/Arginine [Molar ratio] in DBS	C		{Ratio}
IndentIndent53157-4	Citrulline/Phenylalanine [Molar ratio] in DBS	C		{Ratio}
IndentIndent53399-2	Citrulline/Tyrosine [Molar ratio] in DBS	C		{Ratio}
IndentIndent47623-4	Glutamate [Moles/volume] in DBS	C		umol/L
IndentIndent47633-3	Glycine [Moles/volume] in DBS	C		umol/L
IndentIndent93488-5	Guanidinoacetate [Moles/volume] in DBS			umol/L
IndentIndent47643-2	Histidine [Moles/volume] in DBS	C		umol/L
IndentIndent53158-2	Homocitrulline [Moles/volume] in DBS	C		umol/L
IndentIndent47689-5	Lysine [Moles/volume] in DBS	C		umol/L
IndentIndent47700-0	Methionine [Moles/volume] in DBS	C		umol/L
IndentIndent53397-6	Methionine/Alloisoleucine+Isoleucine+Leucine+Hydroxyproline [Molar ratio] in DBS	C		{Ratio}
IndentIndent53156-6	Methionine/Phenylalanine [Molar ratio] in DBS	C		{Ratio}
IndentIndent75215-4	Ornithine/Citrulline [Molar ratio] in DBS	C		{ratio}
IndentIndent29573-3	Phenylalanine [Moles/volume] in DBS	C		umol/L
IndentIndent35572-7	Phenylalanine/Tyrosine [Molar ratio] in DBS	C		{Ratio}
IndentIndent47732-3	Proline [Moles/volume] in DBS	C		umol/L
IndentIndent53392-7	Proline/Phenylalanine [Molar ratio] in DBS	C		{Ratio}
IndentIndent47742-2	Serine [Moles/volume] in DBS	C		umol/L
IndentIndent53231-7	Succinylacetone [Moles/volume] in DBS	C		umol/L
IndentIndent47784-4	Threonine [Moles/volume] in DBS	C		umol/L
IndentIndent53159-0	Tryptophan [Moles/volume] in DBS	C		umol/L
IndentIndent35571-9	Tyrosine [Moles/volume] in DBS	C		umol/L
IndentIndent47799-2	Valine [Moles/volume] in DBS	C		umol/L
IndentIndent53151-7	Valine/Phenylalanine [Molar ratio] in DBS	C		{Ratio}
Indent104191-2	Guanidinoacetate methyltransferase (GAMT) deficiency newborn screening panel
IndentIndent104192-0	Guanidinoacetate methyltransferase deficiency newborn screen interpretation
IndentIndent104194-6	Creatine [Moles/volume] in DBS			mmol/L
IndentIndent104193-8	Guanidinoacetate methyltransferase deficiency comment [Text] in DBS Narrative
IndentIndent93488-5	Guanidinoacetate [Moles/volume] in DBS			umol/L
IndentIndent107506-8	Guanidinoacetate/Creatine [Molar ratio] in DBS			umol/mmol
Indent58092-8	Acylcarnitine newborn screen panel	C
IndentIndent58088-6	Acylcarnitine newborn screen interpretation	C
IndentIndent58093-6	Acylcarnitine newborn screening comment-discussion	C
IndentIndent57084-6	Fatty acid oxidation newborn screen panel	C
IndentIndentIndent46736-5	Fatty acid oxidation defects newborn screen interpretation	C
IndentIndentIndent57792-4	Fatty acid oxidation conditions suspected [Identifier] in DBS	C
IndentIndentIndent57709-8	Fatty acid oxidation defects newborn screening comment-discussion	C
IndentIndentIndent38481-8	Carnitine free (C0) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53233-3	Carnitine free (C0)/Palmitoylcarnitine (C16) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53234-1	Carnitine free (C0)/Stearoylcarnitine (C18) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53235-8	Carnitine free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53236-6	Carnitine.free (C0)+Acetylcarnitine (C2)+Propionylcarnitine (C3)+Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)+Stearoylcarnitine (C18)/Citrulline [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent75211-3	Propionylcarnitine (C3)+Palmitoylcarnitine (C16) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent75212-1	Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBS	C		{ratio}
IndentIndentIndent54462-7	Malonylcarnitine (C3-DC) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent75213-9	Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)/Decanoylcarnitine (C10) [Molar ratio] in DBS	C		{ratio}
IndentIndentIndent50157-7	Acetylcarnitine (C2) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53166-5	Butyrylcarnitine+Isobutyrylcarnitine (C4) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53167-3	Butyrylcarnitine+Isobutyrylcarnitine (C4)/Acetylcarnitine (C2) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53168-1	Butyrylcarnitine+Isobutyrylcarnitine (C4)/Propionylcarnitine (C3) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53169-9	Butyrylcarnitine+Isobutyrylcarnitine (C4)/Octanoylcarnitine (C8) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent50102-3	3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent45211-0	Hexanoylcarnitine (C6) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53173-1	3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent45207-8	Glutarylcarnitine (C5-DC) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53174-9	Octenoylcarnitine (C8:1) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53175-6	Octanoylcarnitine (C8) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53176-4	Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53177-2	Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53178-0	3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53402-4	3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53179-8	3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53180-6	Decadienoylcarnitine (C10:2) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent45198-9	Decenoylcarnitine (C10:1) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent45197-1	Decanoylcarnitine (C10) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53182-2	3-Hydroxydecenoylcarnitine (C10:1-OH) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53183-0	Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53403-2	Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53184-8	Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53185-5	Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53186-3	Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent45200-3	Dodecenoylcarnitine (C12:1) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent45199-7	Dodecanoylcarnitine (C12) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53188-9	3-Hydroxydodecenoylcarnitine (C12:1-OH) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53189-7	3-Hydroxydodecanoylcarnitine (C12-OH) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53190-5	Tetradecadienoylcarnitine (C14:2) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53191-3	Tetradecenoylcarnitine (C14:1) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53192-1	Tetradecanoylcarnitine (C14) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53193-9	Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53194-7	Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53195-4	Tetradecenoylcarnitine (C14:1)/Palmitoylcarnitine (C16) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent70159-9	Tetradecenoylcarnitine (C14:1)/Tetradecanoylcarnitine (C14) [Molar ratio] in DBS	C		{ratio}
IndentIndentIndent53196-2	3-Hydroxytetradecadienoylcarnitine (C14:2-OH) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53197-0	3-Hydroxytetradecenoylcarnitine (C14:1-OH) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent50281-5	3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53198-8	Palmitoleylcarnitine (C16:1) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53199-6	Palmitoylcarnitine (C16) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent50121-3	3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent50125-4	3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53201-0	3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent45217-7	Linoleoylcarnitine (C18:2) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53202-8	Oleoylcarnitine (C18:1) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53241-6	Stearoylcarnitine (C18) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53400-8	Stearoylcarnitine (C18)/Propionylcarnitine (C3) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent50109-8	3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent50113-0	3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent50132-0	3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53836-3	ABCD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
IndentIndent57085-3	Organic acid newborn screen panel	C
IndentIndentIndent46744-9	Organic acidemias newborn screen interpretation	C
IndentIndentIndent57791-6	Organic acidemia conditions suspected [Identifier] in DBS	C
IndentIndentIndent57708-0	Organic acidemias defects newborn screening comment-discussion	C
IndentIndentIndent50157-7	Acetylcarnitine (C2) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53237-4	Acrylylcarnitine (C3:1) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53160-8	Propionylcarnitine (C3) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53161-6	Propionylcarnitine (C3)/Methionine [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53162-4	Propionylcarnitine (C3)/Carnitine.free (C0) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53163-2	Propionylcarnitine (C3)/Acetylcarnitine (C2) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent54462-7	Malonylcarnitine (C3-DC) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent67708-8	Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent75213-9	Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)/Decanoylcarnitine (C10) [Molar ratio] in DBS	C		{ratio}
IndentIndentIndent53164-0	Propionylcarnitine (C3)/Palmitoylcarnitine (C16) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53166-5	Butyrylcarnitine+Isobutyrylcarnitine (C4) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53167-3	Butyrylcarnitine+Isobutyrylcarnitine (C4)/Acetylcarnitine (C2) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53168-1	Butyrylcarnitine+Isobutyrylcarnitine (C4)/Propionylcarnitine (C3) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53169-9	Butyrylcarnitine+Isobutyrylcarnitine (C4)/Octanoylcarnitine (C8) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53170-7	Tiglylcarnitine (C5:1) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent45207-8	Glutarylcarnitine (C5-DC) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent75216-2	Glutarylcarnitine (C5-DC)/Malonylcarnitine (C3-DC) [Molar ratio] in DBS			{ratio}
IndentIndentIndent67701-3	Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent67710-4	Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent67711-2	Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent45216-9	Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53238-2	Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Carnitine.free (C0) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53239-0	Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Acetylcarnitine (C2) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53240-8	Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Propionylcarnitine (C3) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53401-6	Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Octanoylcarnitine (C8) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent50106-4	3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53171-5	3-Hydroxyisovalerylcarnitine (C5-OH)/Carnitine.free (C0) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53172-3	3-Hydroxyisovalerylcarnitine (C5-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53178-0	3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53402-4	3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53179-8	3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent45222-7	Methylmalonylcarnitine (C4-DC) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent67709-6	Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53181-4	Methylmalonylcarnitine (C4-DC)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53183-0	Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53403-2	Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53184-8	Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53185-5	Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53186-3	Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS	C		{Ratio}
IndentIndentIndent53187-1	Methylglutarylcarnitine (C6-DC) [Moles/volume] in DBS	C		umol/L
IndentIndentIndent53165-7	Formiminoglutamate [Moles/volume] in DBS	C		umol/L
Indent54078-1	Cystic fibrosis newborn screening panel	C
IndentIndent46769-6	Cystic fibrosis newborn screen interpretation	R	1..1
IndentIndent57707-2	Cystic fibrosis newborn screening comment-discussion	C
IndentIndent54083-1	CFTR gene mutations found [Identifier] in DBS by Targeted gene mutation analysis Nominal	C
IndentIndent2077-6	Chloride [Moles/volume] in Sweat	C		mmol/L
IndentIndent48633-2	Trypsinogen I Free [Mass/volume] in DBS	C		ug/L
Indent54076-5	Endocrine newborn screening panel	C
IndentIndent57086-1	Congenital adrenal hyperplasia newborn screening panel	C
IndentIndentIndent46758-9	Congenital adrenal hyperplasia newborn screen interpretation	R	1..1
IndentIndentIndent57706-4	Congenital adrenal hyperplasia newborn screening comment-discussion	C
IndentIndentIndent53347-1	11-Deoxycorticosterone [Mass/volume] in DBS	C		ng/dL
IndentIndentIndent53338-0	11-Deoxycortisol [Mass/volume] in DBS	C		ug/dL
IndentIndentIndent38473-5	17-Hydroxyprogesterone [Mass/volume] in DBS	C		ng/mL
IndentIndentIndent53336-4	17-Hydroxyprogesterone+Androstenedione/Cortisol [Mass Ratio] in DBS	C		{ratio}
IndentIndentIndent53341-4	21-Deoxycortisol [Mass/volume] in DBS	C		ug/dL
IndentIndentIndent53343-0	Androstenedione [Mass/volume] in DBS	C		ng/dL
IndentIndentIndent53345-5	Cortisol [Mass/volume] in DBS	C		ug/dL
IndentIndent54090-6	Thyroid newborn screening panel	C
IndentIndentIndent46762-1	Congenital hypothyroidism newborn screen interpretation	R
IndentIndentIndent57705-6	Congenital hypothyroidism newborn screening comment-discussion	C
IndentIndentIndent31144-9	Thyroxine (T4) [Mass/volume] in DBS	C		ug/dL
IndentIndentIndent29575-8	Thyrotropin [Units/volume] in DBS	C		m[IU]/L
Indent54079-9	Galactosemia newborn screening panel	C
IndentIndent46737-3	Galactosemias newborn screen interpretation	R	1..1
IndentIndent57704-9	Galactosemias newborn screening comment-discussion	C
IndentIndent54084-9	Galactose [Mass/volume] in DBS	C		mg/dL
IndentIndent33288-2	Galactose 1 phosphate uridyl transferase [Presence] in DBS	C
IndentIndent42906-8	Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in DBS	C		nmol/h/mL
IndentIndent40842-7	Galactose 1 phosphate [Mass/volume] in DBS	C		mg/dL
Indent54081-5	Hemoglobinopathies newborn screening panel	C
IndentIndent64116-7	Hemoglobin observations newborn screening panel
IndentIndentIndent64122-5	Hemoglobins that can be presumptively identified based on available controls in DBS	C
IndentIndentIndent64117-5	Most predominant hemoglobin in DBS	C
IndentIndentIndent64118-3	Second most predominant hemoglobin in DBS	C
IndentIndentIndent64119-1	Third most predominant hemoglobin in DBS	C
IndentIndentIndent64120-9	Fourth most predominant hemoglobin in DBS	C
IndentIndentIndent64121-7	Fifth most predominant hemoglobin in DBS	C
IndentIndent46740-7	Hemoglobin disorders newborn screen interpretation	R	1..1
IndentIndent57703-1	Hemoglobin disorders newborn screening comment-discussion	C
IndentIndent71592-0	Hemoglobinopathies conditions suspected [Identifier] in DBS	C
IndentIndent54072-4	Hemoglobin A/Hemoglobin.total in DBS	C		%
IndentIndent54069-0	Hemoglobin Barts/Hemoglobin.total in DBS	C		%
IndentIndent54073-2	Hemoglobin C/Hemoglobin.total in DBS	C		%
IndentIndent54070-8	Hemoglobin D/Hemoglobin.total in DBS	C		%
IndentIndent54071-6	Hemoglobin E/Hemoglobin.total in DBS	C		%
IndentIndent54074-0	Hemoglobin F/Hemoglobin.total in DBS	C		%
IndentIndent54068-2	Hemoglobin O - Arab/Hemoglobin.total in DBS	C		%
IndentIndent56476-5	Hemoglobin S/Hemoglobin.total in DBS	C		%
Indent54082-3	Infectious diseases newborn screening panel	C
IndentIndent88535-0	Cytomegalovirus DNA [Presence] in DBS by NAA with probe detection
IndentIndent57702-3	Infectious diseases newborn screen interpretation	R	1..1
IndentIndent57701-5	Infectious diseases newborn screening comment-discussion	C
IndentIndent54086-4	HIV 1+2 IgG Ab [Presence] in DBS	C
IndentIndent54087-2	Toxoplasma gondii IgG Ab [Presence] in DBS	C
IndentIndent54088-0	Toxoplasma gondii IgM Ab [Presence] in DBS	C
Indent57087-9	Biotinidase newborn screening panel	C
IndentIndent46761-3	Biotinidase deficiency newborn screen interpretation	R	1..1
IndentIndent57699-1	Biotinidase deficiency newborn screening comment-discussion	C
IndentIndent38478-4	Biotinidase [Presence] in DBS	C
IndentIndent75217-0	Biotinidase [Enzymatic activity/volume] in DBS	C		nmol/mL/min
Indent58091-0	Glucose-6-Phosphate dehydrogenase newborn screen panel	C
IndentIndent58089-4	Glucose-6-Phosphate dehydrogenase newborn screen interpretation	C
IndentIndent58090-2	Glucose-6-Phosphate dehydrogenase newborn screening comment-discussion	C
IndentIndent33287-4	Glucose-6-Phosphate dehydrogenase [Presence] in DBS	C
Indent62300-9	Lysosomal disorders newborn screening panel	C
IndentIndent104188-8	Mucopolysaccharidosis type II newborn screening panel
IndentIndentIndent79462-8	Iduronate-2-Sulfatase [Enzymatic activity/volume] in DBS			nmol/h/mL
IndentIndentIndent104190-4	Mucopolysaccharidosis type II comment [Text] in DBS Narrative
IndentIndentIndent104189-6	Mucopolysaccharidosis type II newborn screen interpretation newborn screen interpretation
IndentIndent62301-7	Lysosomal disorders newborn screen interpretation	C	0..1
IndentIndent62303-3	Lysosomal disorders newborn screening comment-discussion	C	0..1
IndentIndent62302-5	Lysosomal disorders suspected [Identifier] in DBS	C	0..1
IndentIndent62304-1	Fabry disease newborn screening panel	C
IndentIndentIndent62305-8	Fabry disease newborn screen interpretation	R	0..1
IndentIndentIndent62306-6	Fabry disease newborn screening comment-discussion	C	0..1
IndentIndentIndent55908-8	Alpha galactosidase A [Enzymatic activity/volume] in DBS	C	0..1	umol/L/h
IndentIndent62307-4	Krabbe disease newborn screening panel	C
IndentIndentIndent62308-2	Krabbe disease newborn screen interpretation	R	0..1
IndentIndentIndent62309-0	Krabbe disease newborn screening comment-discussion	C	0..1
IndentIndentIndent62310-8	Galactosylceramidase [Enzymatic activity/volume] in DBS	C	0..1	umol/L/h
IndentIndent62311-6	Gaucher disease newborn screening panel	C
IndentIndentIndent62312-4	Gaucher disease newborn screen interpretation	R	0..1
IndentIndentIndent62313-2	Gaucher disease newborn screening comment-discussion	C	0..1
IndentIndentIndent55917-9	Glucosylceramidase [Enzymatic activity/volume] in DBS	C	0..*	umol/L/h
IndentIndent79563-3	Mucopolysaccharidosis type I newborn screening panel
IndentIndentIndent55909-6	Alpha-L-iduronidase [Enzymatic activity/volume] in DBS			umol/h/L
IndentIndentIndent79564-1	Mucopolysaccharidosis type I newborn screen interpretation
IndentIndentIndent79565-8	Mucopolysaccharidosis type I newborn screening comment-discussion
IndentIndent62315-7	Niemann Pick disease A/B newborn screening panel	C
IndentIndentIndent62318-1	Niemann Pick disease A/B newborn screen interpretation	R	0..1
IndentIndentIndent62319-9	Niemann Pick disease A/B newborn screening comment-discussion	C	0..1
IndentIndentIndent62316-5	Acid sphingomyelinase [Enzymatic activity/volume] in DBS	C	0..1	umol/L/h
IndentIndent63414-7	Pompe disease newborn screening panel	C
IndentIndentIndent63415-4	Pompe disease newborn screen interpretation	R	0..*
IndentIndentIndent63416-2	Pompe disease newborn screening comment-discussion	C	0..*
IndentIndentIndent55827-0	Acid alpha glucosidase [Enzymatic activity/volume] in DBS	C	0..*	umol/L/h
IndentIndent111822-3	Metachromatic leukodystrophy comment newborn screen interpretation
Indent62333-0	Severe combined immunodeficiency (SCID) newborn screening panel	C
IndentIndent62321-5	Severe combined immunodeficiency newborn screen interpretation	R	1..1
IndentIndent62322-3	Severe combined immunodeficiency newborn screening comment-discussion	C	0..1
IndentIndent62320-7	T-cell receptor excision circle [#/volume] in DBS by NAA with probe detection	C	0..1	{copies}
IndentIndent92006-6	T-cell receptor excision circle [Cycle Threshold #] in DBS			{Ct_value}
IndentIndent92007-4	T-cell receptor excision circle [Z-score] in DBS			{Zscore}
IndentIndent92008-2	T-cell receptor excision circle [Multiple of the median] in DBS			{M.o.M}
Indent92005-8	Spinal muscular atrophy newborn screening panel
IndentIndent92004-1	Spinal muscular atrophy newborn screen interpretation
IndentIndent92003-3	Spinal muscular atrophy newborn screening comment-discussion
IndentIndent92002-5	SMN1 gene [Cycle Threshold #] in DBS by NAA with probe detection			{Ct_value}
IndentIndent97654-8	SMN2 gene copy number in Blood or Tissue by Molecular genetics method			{#}
Indent85267-3	X-linked adrenoleukodystrophy (X-ALD) newborn screening panel	C	0..1
IndentIndent85269-9	X-linked adrenoleukodystrophy newborn screen interpretation	C	0..*
IndentIndent85268-1	X-linked adrenoleukodystrophy newborn screening comment-discussion	C	0..*
IndentIndent79321-6	Lysophosphatidylcholine(26:0) [Moles/volume] in DBS	O	0..1	umol/L
Indent57128-1	Newborn Screening Report summary panel	C	0..1
Indent57719-7	Conditions tested for in this newborn screening study [Identifier] in DBS	R	1..*
Indent57129-9	Full newborn screening summary report for display or printing	O	0..1
Indent57724-7	Newborn screening short narrative summary	O	0..1
Indent57720-5	Newborn conditions with equivocal markers [Identifier] in DBS	R	1..*
Indent57721-3	Reason for lab test in Dried blood spot	R	1..1
Indent57131-5	Newborn conditions with positive markers [Identifier] in DBS	R	1..*
Indent57130-7	Newborn screening report - overall interpretation	C	1..*
Indent57718-9	Sample quality of Dried blood spot	R	1..1
Indent69969-4	Newborn screening report overall laboratory comment	O	0..*
Indent57717-1	Newborn screen card data panel	C
IndentIndent57716-3	State printed on filter paper card [Identifier] in NBS card	R
IndentIndent79566-6	Collection method - DBS	O
IndentIndent8339-4	Birthweight	R		[lb_av];kg;g
IndentIndent58229-6	Body weight Measured --when specimen taken	O		[lb_av];kg
IndentIndent57715-5	Time of birth	R		{clock_time}
IndentIndent73806-2	Newborn age in hours	O		h
IndentIndent57722-1	Birth plurality of Pregnancy	R
IndentIndent57714-8	Obstetric estimation of gestational age	R		wk
IndentIndent57713-0	Infant factors that affect newborn screening interpretation	R	1..*
IndentIndent67703-9	Other infant factors that affect newborn screening interpretation Narrative	C	0..*
IndentIndent67706-2	Maternal factors that affect newborn screening interpretation	O	0..*
IndentIndent67707-0	Other maternal factors that affect newborn screening interpretation Narrative	C	0..*
IndentIndent77739-1	Mother's Hepatitis B virus surface Ag status	C
IndentIndent57712-2	Highest level of education Mother	O	0..1
IndentIndent67704-7	Feeding types	R	1..*
IndentIndent67705-4	Other feeding types Narrative	C	0..*
IndentIndent79569-0	Blood product given [Type]	C
IndentIndent62317-3	Date of last blood product transfusion	O	0..1
IndentIndent58232-0	Hearing loss risk indicators [Identifier]	C	1..*
IndentIndent54106-0	Newborn hearing screen method	C
IndentIndent54108-6	Newborn hearing screen of Ear - left	C
IndentIndent54109-4	Newborn hearing screen of Ear - right	C
IndentIndent73700-7	CCHD newborn screening interpretation	C
IndentIndent73698-3	Reason CCHD oxygen saturation screening not performed	C
IndentIndent57723-9	Unique bar code number of Current sample	R
IndentIndent57711-4	Unique bar code number of Initial sample	C
IndentIndent62323-1	Post-discharge provider ID [Identifier]	C	0..1
IndentIndent62324-9	Post-discharge provider name in Provider	C	0..1
IndentIndent62325-6	Post-discharge provider practice ID	C	0..1
IndentIndent62326-4	Post-discharge provider practice name	C	0..1
IndentIndent62327-2	Post-discharge provider practice address	C	0..1
IndentIndent62328-0	Post-discharge provider practice phone number	C	0..1
IndentIndent62329-8	Birth hospital facility ID	C	0..1
IndentIndent62330-6	Birth hospital facility name	C	0..1
IndentIndent62331-4	Birth hospital facility address	C	0..1
IndentIndent62332-2	Birth hospital facility phone number	C	0..1

LOINC Names Get Info

Fully-Specified Name: Newborn screening test results panel:-:Pt:Bld.dot:-:
Long Common Name: Newborn screening test results panel - DBS
Short Name: NBS test results pnl DBS
Display Name: NBS test results panel (DBS)
Consumer Name Alpha Get Info: NBS test results panel, Dried blood spot

Part Model Get Info

Component
Newborn screening test results panel
LP97728-7
- Analyte
  Newborn screening test results panel
  LP97728-7
  - Component Numerator
    Newborn screening test results panel
    LP97728-7
    - Component Numerator Core
      Newborn screening test results panel
      LP97728-7
    - Component Numerator Core Suffix
      NULL
  - Component Denominator
    NULL
    - Component Denominator Core
      NULL
    - Component Denominator Core Suffix
      NULL
- Challenge
  NULL
- Adjustment
  NULL
- Count
  NULL
Property
-
LP6769-6
Time
Pt
LP6960-1
- Time Core
  Pt
  LP6960-1
- Time Modifier
  NULL
System
Bld.dot
LP21304-8
- System Core
  Bld.dot
  LP21304-8
- Super System
  NULL
Scale
-
LP7747-1
Method
NULL

Basic Attributes

Class: PANEL.CHEM
Type: Laboratory
First Released: Version 2.29
Last Updated: Version 2.67 (PANEL)
Order vs. Observation: Order
Panel Type: Organizer

Member of these Panels

LOINC	Long Common Name
54089-8	Newborn screening panel American Health Information Community (AHIC)

Language Variants Get Info

Tag	Language	Translation
ar-JO	Arabic (Jordan)	نتائج فحص حديثي الولادة ( بتقنية فحص الدم الجاف )
cs-CZ	Czech (Czechia)	Novorozenecký screening výsledky testů panel:-:Časový bod:Suchá krevní kapka (DBS):-:
el-GR	Greek (Greece)	Πίνακας αποτελεσμάτων εξετάσεων διαλογής νεογνών:-:Pt:Bld.dot:-: Synonyms: - Bld.dot CHEM PANEL.CHEM Pt Αίμα Πίνακας αποτελεσμάτων εξετάσεων διαλογής νεογνών
es-ES	Spanish (Spain)	Panel de resultados de tests de cribado del recién nacido:Propiedades mixtas (sólo paneles):Punto temporal:gota de sangre (papel de filtro):-:
es-MX	Spanish (Mexico)	Panel de resultados de la prueba de detección del recién nacido:-:Punto temporal:DBS:-:
fr-FR	French (France)	Dépistage néonatal - Résultats des tests panel:-:Ponctuel:Sang buvard:-:
it-IT	Italian (Italy)	Screening neonatale, panel risultati test:-:Pt:Sangue.su carta da filtro:-: Synonyms: Chimica Panel risultati test di screening neonatale Punto nel tempo (episodio) Sangue Set di prescrizione chimica Spot sangue secco
nl-NL	Dutch (Netherlands)	pasgeborene screening testresultaten panel:-:moment:gedroogde bloedspot:-:
pl-PL	Polish (Poland)	Panel wyników badań przesiewowych noworodków:-:punkt w czasie:sucha kropla krwi:-:
pt-BR	Portuguese (Brazil)	Triagem neonatal teste do painel Resultados:#N/A:Pt:SgPapel:-: Synonyms: ; NBS test results pnl; Point in time; Random; DBS; Filter paper; FP; Dried blood spot; Blood; WB; Whole blood; SCN; Asymptomatic; Asympt; Pnl; Pan; Panl; New born; PANEL.CHEMISTRY; PANEL.CHEMISTRY; Chemistry
ru-RU	Russian (Russian Federation)	Новорождённый скрининг тест результаты панель:-:ТчкВрм:Кр.Сух.капл:-: Synonyms: Кровь Кровь сухая капля Точка во времени;Момент
zh-CN	Chinese (China)	新生儿筛查试验结果组套:-:时间点:全血.斑点:-: Synonyms: Asympt SCN 全血斑点(滤纸);滤纸;血液.斑点;血液斑点(滤纸) 化学;化学检验项目;化学检验项目类;化学类;化学试验;非刺激耐受型化学检验项目;非刺激耐受型化学检验项目类;非刺激耐受型化学试验;非刺激耐受型化学试验类医嘱套餐医嘱套餐类医嘱套餐组医嘱组医嘱组.化学试验;化学组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目）;化学医嘱组类;医嘱组.化学;医嘱组.化学检验项目;医嘱组类.化学;医嘱组类.化学检验项目;医嘱组类.化学试验;实验室医嘱组类.化学;实验室医嘱组类.化学检验项目;实验室医嘱组类.化学试验医嘱组合医嘱组合类医嘱组套医嘱组套类医嘱组类多重;多重型;多重标尺类型;多重精度类型套餐套餐医嘱套餐医嘱组套餐医嘱组类实验室医嘱套餐实验室医嘱套餐类实验室医嘱组实验室医嘱组合类实验室医嘱组套实验室医嘱组套类实验室套餐医嘱组实验室套餐医嘱组类实验室检验项目医嘱组合类实验室检验项目组合类新生儿（NB）筛查（筛选、过筛、筛检）试验结果组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目）;新生儿筛查试验结果组套;新生儿筛查试验结果组合;新生儿筛查检验结果医嘱组无症状无症状（Asymptomatic，Asympt）无症状的无症状筛查时刻;随机;随意;瞬间普查普查试验检验医嘱组合类检验项目医嘱组合类检验项目组合类筛分筛分试验筛查（Screening，SCN）筛查试验筛选筛选试验组组合组合医嘱组合类组套血;血液

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

CodeSystem lookup: https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=57794-0
Questionnaire definition: https://fhir.loinc.org/Questionnaire/?url=http://loinc.org/q/57794-0

LOINC Copyright

Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.